LabCompass

Chafiq Hamdouchi

Chemistry · Indiana University

OpenAlex ORCID
Established · publishing since 1988
Asymmetric Synthesis and CatalysisSynthesis and Characterization of Heterocyclic CompoundsSynthesis and Reactivity of HeterocyclesChemical Synthesis and ReactionsQuinazolinone synthesis and applications

Publications

81

Citations

1,882

Est. group size

—

Recurring co-author estimate

Active years

38

Publishing since 1988

Research summary
AI-generated

Chafiq Hamdouchi works in medicinal and synthetic chemistry, focusing on designing and making drug-like small molecules. Much of the recent work centers on GPR40 (also called FFAR1), a receptor targeted for treating type 2 diabetes, including the discovery and early development of candidate compounds. The research combines organic synthesis with understanding how molecules bind to and activate biological targets.

Medicinal chemistry and drug discoveryGPR40/FFAR1 agonists for type 2 diabetesHeterocyclic compound synthesisAsymmetric synthesis and catalysisStructure-based molecule design

Publication activity has been low and intermittent over the past decade, averaging under one indexed paper per year.

Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026

Funding
Public award records

Current awards run through February 2027 — about under a year of funding on record from today. Awards are often renewed, so this is what is currently public, not a forecast.

  • ActiveNIH R01NS126358through Feb 2027 · $425k awarded

    Development of BBB-permeable SUMO1 small molecule degraders for glioblastoma therapy.

Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.

In context
Among 193 established Chemistry PIs within our index
Citations: 1,882cohort median 2,518
h-index: 24cohort median 26
Publications / year (recent): 0.8cohort median 3.4

Typically publishes in teams of ~26 · 0% small-team papers (≤3 authors) · across 4 venues

Publication cadence
Publications per year over the last 10 years — averaging 0.8/year recently
2017: 2 publications2172018: 1 publication1819202021: 1 publication21222023: 1 publication232024: 1 publication242025: 2 publications22526
Collaborators per year
Distinct co-authors at Indiana University each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
2017: 0 collaborators at the same institution2018: 0 collaborators at the same institution2019: 0 collaborators at the same institution2020: 0 collaborators at the same institution2021: 0 collaborators at the same institution2022: 0 collaborators at the same institution2023: 0 collaborators at the same institution2024: 0 collaborators at the same institution2025: 6 collaborators at the same institution1719212325
Recent publications
Publishes in
  • Journal of Medicinal Chemistry×3
  • Nature Communications×1
  • Science Translational Medicine×1
  • Pharmacological Research×1
  • Pharmacology Research & Perspectives×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 27, 2026.

Claim or correct this profile